SELLAS Life Sciences (SLS) Tax Rate (2013 - 2017)
SELLAS Life Sciences (SLS) reported Tax Rate of 0.85% for Q4 2017, up 39.73% quarter-over-quarter from 1.41% in Q3 2017.
SELLAS Life Sciences (SLS) Tax Rate (2013 - 2017) Analysis & Trends
SELLAS Life Sciences (SLS) has 2 years of Tax Rate data on file, last reported at 0.85% in Q4 2017.
- Tax Rate for Q4 2017 came in at 0.85%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2017 was 1.1% (changed N/A YoY), and the FY2021 annual result was 1.13%, up 103.0% from the prior year.
- Tax Rate rose to 0.85% in Q4 2017 per SLS's latest filing, from 1.41% in the prior quarter.
- Over five years, Tax Rate peaked at 22.91% in Q1 2013 and troughed at 19.13% in Q2 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | SELLAS Life Sciences | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -0.85% |
| Dec 31, 2017 | -0.85% |
| Sep 30, 2017 | -1.41% |
| Sep 30, 2017 | -1.41% |
| Jun 30, 2017 | -2.38% |
| Jun 30, 2017 | -2.38% |
| Dec 31, 2013 | -2.65% |
| Dec 31, 2013 | -2.65% |
| Sep 30, 2013 | -14.26% |
| Sep 30, 2013 | -14.26% |
| Jun 30, 2013 | -19.13% |
| Jun 30, 2013 | -19.13% |
| Mar 31, 2013 | 22.91% |
| Mar 31, 2013 | 22.91% |